[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"menu":3,"$fDUbFtbPhQ6aWI1JozlCaFBDHxU19dFotNP4u2ryJkEc":210},{"main":4,"mainTranslated":17,"footer":45,"footerTranslated":109},[5,8,11,14],{"title":6,"url":7},"Course library","https:\u002F\u002Fwww.medmastery.com\u002Fcourse-library",{"title":9,"url":10},"Pricing","https:\u002F\u002Fwww.medmastery.com\u002Fpricing",{"title":12,"url":13},"Earn credits","https:\u002F\u002Fwww.medmastery.com\u002Fcme-credits",{"title":15,"url":16},"Institutions","https:\u002F\u002Fwww.medmastery.com\u002Finstitutions",{"de":18,"es":27,"fr":36},[19,21,23,25],{"title":20,"url":7},"Kurse",{"title":22,"url":10},"Preise",{"title":24,"url":13},"CME-Punkte",{"title":26,"url":16},"Organisationen",[28,30,32,34],{"title":29,"url":7},"Biblioteca de cursos",{"title":31,"url":10},"Precios",{"title":33,"url":13},"Gana créditos",{"title":35,"url":16},"Instituciones",[37,39,41,43],{"title":38,"url":7},"Cours",{"title":40,"url":10},"Tarifs",{"title":42,"url":13},"Obtenir des crédits",{"title":44,"url":16},"Établissements",[46,59,79,97],{"title":47,"group":48,"menu":49},"Company",true,[50,53,56],{"title":51,"url":52},"Our teachers","https:\u002F\u002Fwww.medmastery.com\u002Fteachers",{"title":54,"url":55},"About us","https:\u002F\u002Fwww.medmastery.com\u002Fabout-us",{"title":57,"url":58},"Work with us","https:\u002F\u002Fwww.medmastery.com\u002Fwork-with-us",{"title":60,"group":48,"menu":61},"Product",[62,64,67,70,73,76,78],{"title":63,"url":7},"Courses",{"title":65,"url":66},"Magazine","https:\u002F\u002Fwww.medmastery.com\u002Fmagazine",{"title":68,"url":69},"Podcast","https:\u002F\u002Fwww.medmastery.com\u002Fpodcasts",{"title":71,"url":72},"Webinars","https:\u002F\u002Fwww.medmastery.com\u002Fwebinars",{"title":74,"url":75},"Guides","https:\u002F\u002Fwww.medmastery.com\u002Fguides",{"title":15,"url":77},"https:\u002F\u002Fwww.medmastery.com\u002Finstitutions\u002F",{"title":9,"url":10},{"title":80,"group":48,"menu":81},"Legal",[82,85,88,91,94],{"title":83,"url":84},"Imprint","https:\u002F\u002Fwww.medmastery.com\u002Fimprint",{"title":86,"url":87},"Newsletter policy","https:\u002F\u002Fwww.medmastery.com\u002Fnewsletter-privacy-policy",{"title":89,"url":90},"Privacy policy","https:\u002F\u002Fwww.medmastery.com\u002Fprivacy-policy",{"title":92,"url":93},"Cookie Policy","https:\u002F\u002Fwww.medmastery.com\u002Fcookie-policy",{"title":95,"url":96},"Terms","https:\u002F\u002Fwww.medmastery.com\u002Fterms",{"title":98,"group":48,"menu":99},"Customer support",[100,103,106],{"title":101,"url":102},"FAQs","https:\u002F\u002Fwww.medmastery.com\u002Ffaqs",{"title":104,"url":105},"Contact","https:\u002F\u002Fwww.medmastery.com\u002Fcontact",{"title":107,"url":108},"support@medmastery.com","mailto:support@medmastery.com",{"de":110,"es":143,"fr":177},[111,118,128,137],{"title":112,"group":48,"menu":113},"Unternehmen",[114,116,117],{"title":115,"url":52},"Unsere Dozentinnen und Dozenten",{"title":54,"url":55},{"title":57,"url":58},{"title":119,"group":48,"menu":120},"Produkt",[121,122,123,124,125,126,127],{"title":20,"url":7},{"title":65,"url":66},{"title":68,"url":69},{"title":71,"url":72},{"title":74,"url":75},{"title":26,"url":77},{"title":22,"url":10},{"title":129,"group":48,"menu":130},"Rechtliches",[131,133,134,135,136],{"title":132,"url":84},"Impressum",{"title":86,"url":87},{"title":89,"url":90},{"title":92,"url":93},{"title":95,"url":96},{"title":138,"group":48,"menu":139},"Kundenservice",[140,141,142],{"title":101,"url":102},{"title":104,"url":105},{"title":107,"url":108},[144,151,162,171],{"title":145,"group":48,"menu":146},"Empresa",[147,149,150],{"title":148,"url":52},"Nuestros profesores",{"title":54,"url":55},{"title":57,"url":58},{"title":152,"group":48,"menu":153},"Producto",[154,156,157,158,159,160,161],{"title":155,"url":7},"Cursos",{"title":65,"url":66},{"title":68,"url":69},{"title":71,"url":72},{"title":74,"url":75},{"title":35,"url":77},{"title":31,"url":10},{"title":163,"group":48,"menu":164},"Información legal",[165,167,168,169,170],{"title":166,"url":84},"Aviso legal",{"title":86,"url":87},{"title":89,"url":90},{"title":92,"url":93},{"title":95,"url":96},{"title":172,"group":48,"menu":173},"Atención al cliente",[174,175,176],{"title":101,"url":102},{"title":104,"url":105},{"title":107,"url":108},[178,185,196,204],{"title":179,"group":48,"menu":180},"Entreprise",[181,183,184],{"title":182,"url":52},"Nos enseignants",{"title":54,"url":55},{"title":57,"url":58},{"title":186,"group":48,"menu":187},"Produit",[188,189,190,191,192,193,194],{"title":38,"url":7},{"title":65,"url":66},{"title":68,"url":69},{"title":71,"url":72},{"title":74,"url":75},{"title":15,"url":77},{"title":195,"url":10},"Tarification",{"title":197,"group":48,"menu":198},"Mentions légales",[199,200,201,202,203],{"title":197,"url":84},{"title":86,"url":87},{"title":89,"url":90},{"title":92,"url":93},{"title":95,"url":96},{"title":205,"group":48,"menu":206},"Service client",[207,208,209],{"title":101,"url":102},{"title":104,"url":105},{"title":107,"url":108},{"content":211,"related":299,"meta":366,"internal":377},{"title":212,"leadIn":213,"category":214,"elements":217,"becomeAnExpert":247,"author":285,"readDuration":297,"readDurationFormatted":298},"When and how to test for hyperlipidemia in clinical practice","Knowing when to test for hyperlipidemia—and what to do with the results—can help reduce your patients' risk of a cardiovascular event. In this lesson, learn who needs early screening, which lipid measures to prioritize, and how to translate those results into actionable risk management.",{"id":215,"name":216},1,"Course previews",[218,229,234,242],{"type":219,"data":220},"video",{"readDurationInSeconds":221,"video":222},454,{"platform":223,"name":224,"url":225,"size":226},"YouTube","Screening for Hyperlipidemia: Who & When | Lipid Profile Test & Calculating Cardiovascular Risk","https:\u002F\u002Fyoutu.be\u002FBPZ3nVMBO24",{"width":227,"height":228},200,113,{"type":230,"data":231},"free_text",{"readDurationInSeconds":232,"text":233},22.666666666666668,"\u003Cp>\u003Cspan>Treating lipid disorders in high-risk patients significantly reduces their likelihood of a cardiovascular event—but did you know that screening thresholds differ by sex, age, and risk profile? The measures you request and how you use them will give you a clear picture of your patient's cardiovascular risk.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan>In this lesson from our \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.medmastery.com\u002Fcourses\u002Fhyperlipidemia-essentials\">\u003Cspan>Hyperlipidemia Essentials course\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan> you’ll learn how to:\u003C\u002Fspan>\u003C\u002Fp>\u003Cul>\u003Cli dir=\"ltr\" data-list-item-id=\"eee2f18af91c9b1b92d11091ce56d4de9\">\u003Cspan>Identify who and when to test for hyperlipidemia\u003C\u002Fspan>\u003C\u002Fli>\u003Cli dir=\"ltr\" data-list-item-id=\"e6aaeb168a220a9f6bf0185626443ed14\">\u003Cspan>Select the right measures for a lipid panel\u003C\u002Fspan>\u003C\u002Fli>\u003Cli dir=\"ltr\" data-list-item-id=\"ebd7b597766e7eaf73589608378ecb15a\">\u003Cspan>Decide when a fasting lipid panel is necessary\u003C\u002Fspan>\u003C\u002Fli>\u003Cli dir=\"ltr\" data-list-item-id=\"ea6d8ac42e902d7cb9ae1c581725b5dff\">\u003Cspan>Use a cardiovascular risk calculator to estimate 10-year CVD risk\u003C\u002Fspan>\u003C\u002Fli>\u003Cli dir=\"ltr\" data-list-item-id=\"e8389cf90b54d1b64d584e8cd36f74899\">\u003Cspan>Stratify patients into four cardiovascular risk categories\u003C\u002Fspan>\u003C\u002Fli>\u003C\u002Ful>",{"type":235,"data":236},"cta",{"readDurationInSeconds":237,"text":238,"buttonText":239,"buttonUrl":240,"teachIllustration":241},3.466666666666667,"Start the first chapter of our Hyperlipidemia Essentials course for free","Start chapter 1 now","https:\u002F\u002Fwww.medmastery.com\u002Fuser\u002Fregister?target=%2Fcourses%2Fhyperlipidemia-essentials","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F9e69bd56-6248-483e-a304-3f73132e69ee",{"type":230,"data":243},{"readDurationInSeconds":244,"title":245,"text":246},207.20000000000002,"Transcript","\u003Ch3 dir=\"ltr\" id=\"docs-internal-guid-1d43a66e-7fff-5ba3-09aa-c5021bb51882\">\u003Cspan>Why test for hyperlipidemia?\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[00:00]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>Understanding the connection between elevated LDL levels and the risk of cardiovascular disease is essential, because treating lipid disorders in patients at high risk significantly reduces their likelihood of experiencing cardiovascular events. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Global differences in lipid screening\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[00:16]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>However, the approaches to assessing and managing risk can vary widely between countries. For example, while many countries use risk calculators to guide treatment, these often overlook key predictors like LDL, ApoB and Lp(a), which are among the strongest indicators of risk. Additionally, the use of cardiac CT imaging for screening is becoming more common, though its availability differs across regions. While screening approaches differ globally, this lesson focuses on guidelines and practices commonly used in the United States. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Who to test for hyperlipidemia\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[00:56]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>So who should be screened for hyperlipidemia? For individuals without known risk factors, routine screening should start at age 35 for males and age 45 for females. Patients with known risk factors should be screened earlier. For males, screening should be between ages 25 and 30 and for females, it should be between ages 30 and 35. Several risk factors increase CVD risk, including being male, aging, hypertension, diabetes, smoking, obesity, a sedentary lifestyle and a family history of premature CVD.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Family history considerations\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[01:36]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>A family history is defined as having a first-degree male relative diagnosed before age 55 or a first-degree female relative diagnosed before age 65. All adults should be screened whenever they begin care with a new primary care provider.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>When to repeat a lipid panel\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[01:55]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>If the results are normal, meaning LDL cholesterol is below 100 mg \u002F dL and triglycerides are below 150 mg \u002F dL, rescreening every five years is sufficient. Patients with LDL levels near treatment thresholds, typically between 100 and 160 mg \u002F dL, depending on other risk factors, should be rescreened every three years. Lipid levels tend to drop in older adults, so screening can stop at age 65 for those with consistently normal results. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>What to include in a lipid panel\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[02:32]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>Now, which blood tests are used for lipid screening? A full lipid profile is essential. This includes total cholesterol, low density lipoprotein, or LDL, high density lipoprotein, or HDL, and triglycerides. It's important to measure apolipoprotein B, or ApoB, and lipoprotein(a), or Lp(a), which are stronger predictors of cardiovascular risk.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Fasting vs. non-fasting\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[03:00]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>While most laboratories recommend fasting for lipid tests, cholesterol levels don't change much between fasting and non-fasting states. However, non-fasting triglyceride levels are more predictive of cardiovascular events. Patients at higher risk for hypertriglyceridemia include those who are overweight, have type 2 diabetes, consume significant amounts of alcohol, or take medications known to raise triglyceride levels, like steroids. For patients with hypertriglyceridemia or a family history of genetic hyperlipidemia, fasting lipid profiles should always be performed initially. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Estimating cardiovascular risk\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[03:41]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>Once we have the lipid profile results, we can estimate cardiovascular risk for patients needing primary prevention using a risk calculator. There are multiple risk models, but not all will suit all patients. You will want to select a CVD risk calculator from the course handbook that is most appropriate for the patient population in your geographic region. Risk calculators incorporate risks like age, sex, race, total cholesterol, HDL, blood pressure, diabetes, family history of premature CVD and smoking status. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Risk calculators by region\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[04:20]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>In the United States, the American College of Cardiology and the American Heart Association use the Prevent Calculator. Across Europe, including the United Kingdom, the European Society of Cardiology has introduced the updated SCORE2 tool, and China relies on the China-PAR Calculator. Let's see how the Prevent Calculator works with a couple of examples.\u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Applying the risk calculator\u003C\u002Fspan>\u003C\u002Fh3>\u003Ch4 dir=\"ltr\">\u003Cspan>Low-risk profile, 43-year-old female\u003C\u002Fspan>\u003C\u002Fh4>\u003Cp dir=\"ltr\">\u003Cspan>[04:45]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>First, meet a 43-year-old female. Her total cholesterol is 130 mg \u002F dL, HDL is 60 mg \u002F dL, and her systolic blood pressure is 120 mmHg. Her BMI is 30 and her estimated glomerular filtration rate, or eGFR, is 95. She doesn't have diabetes, doesn't smoke, hasn't been treated for high blood pressure, and isn't on cholesterol lowering medications. We can determine that her 10 year CVD risk is 0.7% and her lifetime CVD risk is 6%. Let's look at another example. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch4 dir=\"ltr\">\u003Cspan>High-risk profile, 55-year-old male\u003C\u002Fspan>\u003C\u002Fh4>\u003Cp dir=\"ltr\">\u003Cspan>[05:27]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>Now let's look at a 55-year-old male. His total cholesterol is 180, HDL is 20, systolic blood pressure is 118, his BMI is 20, and his eGFR is 110. He has diabetes, smokes cigarettes, and is being treated for hypertension. He's also on a statin. Using the same calculator, his 10 year CVD risk is 18.7% and his lifetime CVD risk is 49.5%. These examples highlight how additional risk factors can dramatically increase both 10 year and lifetime cardiovascular risk. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Patients who require treatment regardless of risk\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[06:10]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>There are two special patient populations to consider, those with diabetes and those with severe hypercholesterolemia, defined as an LDL level greater than 190 mg \u002F dL. These patients require treatment regardless of their calculated risk, but we'll dive into their management in another Medmastery lesson. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Cardiovascular risk stratification: the four categories\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[06:31]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>Once screening is complete and the 10 year cardiovascular risk is calculated, patients fall into one of four categories. Low risk with less than 5%, borderline risk between 5 and 7.4%, intermediate risk from 7.5 to 19.9%, and high risk at 20% or more. \u003C\u002Fspan>\u003C\u002Fp>\u003Ch3 dir=\"ltr\">\u003Cspan>Beyond the lipid panel: imaging for cardiovascular risk\u003C\u002Fspan>\u003C\u002Fh3>\u003Cp dir=\"ltr\">\u003Cspan>[06:54]\u003C\u002Fspan>\u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cspan>Imaging tools such as coronary artery calcium, or CAC, scoring and CT angiography are increasingly used to assess risk more accurately and guide lipid management. We'll explore these imaging techniques in more detail in a later lesson.\u003C\u002Fspan>\u003C\u002Fp>",{"courses":248,"showAwardsBelow":48},[249,269],{"id":250,"isFreeCmeCourse":251,"title":252,"type":253,"specialization":254,"teachers":256,"cmeCredits":258,"teacherIllustration":259,"backgroundImage":260,"relativeUrl":261,"lastChanged":262,"created":263,"description":264,"relativeURL":261,"meta":265},5510,false,"Cardiology Lab Essentials","course",[255],"Cardiology",[257],"Anna Wonnerth, MD",3,"https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F99f55e87-d664-44f3-8684-6cf291cb0863","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F99f55e88-ae2c-4828-816c-1e49f773c3c4","\u002Fcourses\u002Fcardiology-lab-essentials","1763556344","1539019847","The modern cardiology labs landscape can be very confusing. This course will help clear things up for you. Learn to order and interpret lab tests for various conditions (including myocardial infarction, heart failure, dyslipidemia, and pulmonary embolism) as well as common pitfalls and how to avoid them. What you learn here will result in a direct and immediate impact on the way you treat your patients.",{"duration":266,"quizzes":267,"lessons":268},9069,5,37,{"id":270,"isFreeCmeCourse":251,"title":271,"type":253,"specialization":272,"teachers":273,"cmeCredits":215,"teacherIllustration":275,"backgroundImage":276,"relativeUrl":277,"lastChanged":278,"created":279,"description":280,"relativeURL":277,"meta":281},10336,"Hypertension Mini",[255],[274],"Franz Wiesbauer, MD MPH","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F99f55ea4-0fcd-4aee-a883-e80d1132ae0c","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F99f55ea4-eeb8-4aef-b9ad-40de0ee8e824","\u002Fcourses\u002Fhypertension-mini","1763556347","1647215867","With so many antihypertensive agents to choose from, determining which medications to use can be daunting. In this course, we’ll break down the most recent hypertension guidelines and tell you when to use (or not to use) the top four, first-line agents. This will help you to quickly and effectively make treatment decisions for the majority of your patients.",{"duration":282,"quizzes":283,"lessons":284},2314,2,13,{"id":286,"name":274,"image":287,"profession":288,"relativeUrl":291,"specializations":292},1563,"https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F9c43cef0-41ee-4005-9e4a-d8711c816401",{"name":289,"description":290},"Internist","Franz is the founder and CEO of Medmastery. He is an internist with a specialization in cardiology and a master’s in public health from Johns Hopkins University.","\u002Fteachers\u002Ffranz-wiesbauer-md-mph",[293,294,255,295,296],"Nephrology","Professional development","Ultrasound","Emergency medicine and critical care",246,"5m",[300,322,341],{"id":301,"title":302,"text":303,"image":304,"author":312,"path":315,"readDuration":316,"readDurationFormatted":317,"internal":318},1351,"Starting statins as first-line therapy for hyperlipidemia","Starting statins: how to choose the right agent for your patient, match statin intensity to cardiovascular risk, and monitor effectively after initiation.",{"alt":305,"title":306,"size":307,"location":309},"Healthcare provider discussing starting statins with a patient and reviewing a medication bottle","",{"width":308,"height":308},660,{"bucket":310,"key":311},"public-drupal-medmastery-assets-production","\u002F2026-05\u002FC121(2)_magazine image.png",{"id":286,"title":274,"relativeURL":291,"image":287,"professionLong":290,"profession":313,"weight":314},{"name":289},4,"\u002Fmagazine\u002Fstarting-statins-first-line-therapy",238,"4m",{"created":319,"updated":320,"published":321},1778960150,1778962081,1778961827,{"id":323,"title":324,"text":325,"image":326,"author":332,"path":334,"readDuration":335,"readDurationFormatted":336,"internal":337},1350,"How to recognize INOCA (ANOCA) on an exercise stress test ","Angina, abnormal stress test, clean coronaries—that's INOCA (or ANOCA), and it carries real risk. Learn to recognize and report it with exercise stress ECG.",{"alt":327,"title":306,"size":328,"location":330},"Illustration of the heart's coronary vasculature showing large coronary arteries and the extensive network of smaller vessels affected in INOCA (ischemia with nonobstructive coronary arteries).",{"width":329,"height":329},1200,{"bucket":310,"key":331},"\u002F2026-05\u002FC17(1)_magazine image_0.png",{"id":286,"title":274,"relativeURL":291,"image":287,"professionLong":290,"profession":333,"weight":314},{"name":289},"\u002Fmagazine\u002Fexercise-stress-ecg-inoca",141,"3m",{"created":338,"updated":339,"published":340},1778115738,1778799792,1778118255,{"id":342,"title":343,"text":344,"image":345,"author":351,"path":360,"readDuration":361,"readDurationFormatted":317,"internal":362},1347,"Outpatient care for COPD exacerbations","Most acute COPD exacerbations can be managed with outpatient treatment. Learn how to treat mild and moderate COPD exacerbations—and when to escalate care.",{"alt":346,"title":306,"size":347,"location":349},"Older patient using a handheld nebulizer to inhale bronchodilator medication during an acute COPD exacerbation",{"width":348,"height":348},600,{"bucket":310,"key":350},"\u002F2026-04\u002FC133(4)_ exacerbations_magazine image.png",{"id":352,"title":353,"relativeURL":354,"image":355,"professionLong":356,"profession":357,"weight":359},5365,"Siamak Moayedi, MD","\u002Fteachers\u002Fsiamak-moayedi-md","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F9c43cf02-1064-4074-817b-0eb5de6ded74","Professor and Director of Medical Student Education, University of Maryland and Course Director, Essential and Critical Procedures, Emergency Medicine.",{"name":358},"Emergency medicine physician",1533,"\u002Fmagazine\u002Facute-copd-exacerbation-treatment",191,{"created":363,"updated":364,"published":365},1776705362,1776710540,1776710541,{"seo":367,"og":370},{"title":368,"description":369},"When and How to Test for Hyperlipidemia in Practice | Medmastery","Know when to test for hyperlipidemia, which lipid measures to request, and how to use results to guide cardiovascular risk management in clinical practice.",{"title":368,"description":369,"image":371},{"alt":372,"title":306,"size":373,"location":375},"Lipid panel blood sample tubes used to test for hyperlipidemia in a laboratory setting",{"width":329,"height":374},630,{"bucket":310,"key":376},"\u002F2026-04\u002FC121_Open graph_1200x630.png",{"id":378,"created":379,"updated":380,"published":381},1348,1777403036,1777572381,1777412421]